Increasing the use of HIV prevention medication.
RFA-PS-21-003: PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices
This study is all about making it easier for people at risk of HIV to access and use PrEP, a medication that helps prevent HIV, by finding out what stops them from using it and creating helpful programs to encourage informed choices about it.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Florida State University NIH-funded |
| Lab location | 1 site (Tallahassee, United States) |
| Project ID | NIH-10843030 on NIH RePORTER |
What this research studies
This research focuses on enhancing the accessibility and utilization of HIV pre-exposure prophylaxis (PrEP) among individuals at risk of HIV infection. It aims to identify barriers to PrEP uptake and develop strategies to promote informed decision-making regarding its use. By engaging with communities and healthcare providers, the research seeks to create tailored interventions that encourage more people to consider and use PrEP as a preventive measure against HIV. The methodology may include surveys, educational programs, and outreach initiatives to raise awareness and support for PrEP.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for HIV who are considering preventive options.
Not a fit: Patients who are not at risk for HIV or those who are already using PrEP may not receive additional benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of individuals using PrEP, thereby reducing the incidence of HIV infections.
How similar studies have performed: Previous research has shown that targeted interventions can effectively increase PrEP uptake, indicating a promising approach for this study.
Where this research is happening
Tallahassee, United States
- Florida State University — Tallahassee, United States (Active)
Researchers
- Principal investigator: Hightow-Weidman, Lisa B — Florida State University
- Study coordinator: Hightow-Weidman, Lisa B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.